Stearyl gallate
Based on 1 publication(s) in Google Scholar
Stearyl gallate is an alkyl gallate with a long alkyl chain (carbon number of 18). Stearyl gallate has an antioxidant activity, and a weak antiviral activity against HSV-1.
For research use only. We do not sell to patients.
- Purity : 99.50%
- CAS No.: 10361-12-3
- Formula: C25H42O5
- Molecular Weight:422.60
-
Storage:
Store at room temperature, keep dry and cool.
In solvent -80°C, 1 year , -20°C, 6 months
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biological Activity
-
Chemical Information
-
Solvent & Solubility
- Protocols
- Purity & Documentation
- References
-
Help & FAQs
-
HY-N2004
IsoborneolHSV Inhibitor -
HY-U00124B
Tromantadine hydrochlorideHSV Replication Inhibitor -
HY-15303
PritelivirHSV Inhibitor -
HY-15303A
Pritelivir mesylateHelicase-primase Complex Inhibitor -
HY-15303B
Pritelivir mesylate hydrateHelicase-primase Complex Inhibitor -
HY-B0222
1-DocosanolHSV Inhibitor -
HY-U00124
Tromantadine -
HY-19333
OG-L002LSD1 Inhibitor -
HY-N2004R
Isoborneol (Standard)HSV Inhibitor -
HY-15303AR
Pritelivir mesylate (Standard)Helicase-primase Complex Inhibitor -
HY-16721
CyclopropavirAnti-herpesvirus Agent -
HY-79457
S-Methylisothiourea sulfateiNOS Inhibitor
Publications Citing Use of MedChemExpress (MCE) Stearyl gallate
More
Biological Activity
Description
IC50 & Target
[1]|
HSV-1 |
Cellular Effect
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| HL-60 | IC50 |
2.8 μM
Compound: 6d
|
Antiproliferative activity against human HL60 cells after 3 days
Antiproliferative activity against human HL60 cells after 3 days
|
[PMID: 18693020] |
Chemical Information
-
CAS No. 10361-12-3
-
Appearance Solid
-
Molecular Weight 422.60
-
Formula C25H42O5
-
Color White to off-white
-
SMILES
O=C(OCCCCCCCCCCCCCCCCCC)C1=CC(O)=C(O)C(O)=C1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Store at room temperature, keep dry and cool
In solvent -80°C 1 year -20°C 6 months
Publications (1)
-
Journal Impact Factor
-
Most Recent
Solvent & Solubility
In Vitro:
DMSO : 116.67 mg/mL (276.08 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Protocols
-
Research Protocol for Infectious Diseases
Infectious-disease experiments test how pathogens interact with host barriers, innate immune receptors, inflammatory signaling, pathogen replication, and tissue injury; pattern-recognition receptors such as TLRs, RIG-I-like receptors, NOD-like receptors, and inflammasomes detect microbial molecules and activate NF-κB, interferon, and cytokine responses. The central hypothesis is that infection severity reflects the balance between pathogen burden and host response: protective inflammation restricts pathogen growth, whereas excessive or mislocalized inflammation contributes to tissue damage and disease phenotype. Unresolved questions include which host pathways are protective versus pathogenic, why some infection models fail to translate to human disease, and which combined readouts best predict clinically relevant infection outcomes.
Purity & Documentation
-
Data Sheet (265 KB)
-
SDS (393 KB)
- English - EN (393 KB)
- Français - FR (393 KB)
- Deutsch - DE (393 KB)
- Norwegian - NO (393 KB)
- Español - ES (393 KB)
- Swedish - SV (393 KB)
- Italian - IT (393 KB)
- Korean - KR (393 KB)
- Portuguese - PT (393 KB)
-
Handling Instructions (2659 KB)
References
[1]. Misao Uozaki, et al. Antiviral effect of octyl gallate against DNA and RNA viruses. Antiviral Res. 2007 Feb;73(2):85-91. [Content Brief]
[2]. Eisuke Takai, et al. Effects of alkyl chain length of gallate on self-association and membrane binding. J Biochem. 2011 Aug;150(2):165-71. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 1 year; -20°C, 6 months. When stored at -80°C, please use it within 1 year. When stored at -20°C, please use it within 6 months.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 2.3663 mL | 11.8315 mL | 23.6630 mL | 59.1576 mL |
| 5 mM | 0.4733 mL | 2.3663 mL | 4.7326 mL | 11.8315 mL | |
| 10 mM | 0.2366 mL | 1.1832 mL | 2.3663 mL | 5.9158 mL | |
| 15 mM | 0.1578 mL | 0.7888 mL | 1.5775 mL | 3.9438 mL | |
| 20 mM | 0.1183 mL | 0.5916 mL | 1.1832 mL | 2.9579 mL | |
| 25 mM | 0.0947 mL | 0.4733 mL | 0.9465 mL | 2.3663 mL | |
| 30 mM | 0.0789 mL | 0.3944 mL | 0.7888 mL | 1.9719 mL | |
| 40 mM | 0.0592 mL | 0.2958 mL | 0.5916 mL | 1.4789 mL | |
| 50 mM | 0.0473 mL | 0.2366 mL | 0.4733 mL | 1.1832 mL | |
| 60 mM | 0.0394 mL | 0.1972 mL | 0.3944 mL | 0.9860 mL | |
| 80 mM | 0.0296 mL | 0.1479 mL | 0.2958 mL | 0.7395 mL | |
| 100 mM | 0.0237 mL | 0.1183 mL | 0.2366 mL | 0.5916 mL |
Stearyl gallate Related Classifications
HY-N8082 Related Classifications
Powered by Bioz